TrialBlood2025

Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.

Austin Kulasekararaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.